Biodg Inc

Halozyme Therapeutics Inc, based in San Diego, CA, is dedicated to transforming the patient experience through innovative drug delivery technologies. With a focus on easing the burden of treatment and enhancing patient outcomes, the company boasts a robust commercial portfolio that underscores its commitment to patient-centric solutions. By leveraging disruptive technologies such as ENHANZE and various auto-injector and multi-dose pen systems, Halozyme aims to revolutionize how therapies are administered. The company prioritizes corporate responsibility, diversity, and inclusion as integral components of its mission to improve healthcare delivery. Generated from the website

Cardium Therapeutics Inc, located in San Diego, CA, is involved in innovative therapeutic solutions aimed at addressing various health challenges. The company's dedication to advancing medical technologies reflects its commitment to improving patient outcomes and enhancing healthcare delivery. As a forward-thinking entity in the biotechnology sector, Cardium focuses on developing and commercializing products that leverage cutting-edge scientific research. Its strategic approach to partnerships and collaborations further strengthens its position within the industry, driving progress in therapeutic advancements. Generated from the website

Located in San Diego, Cardium Therapeutics is a medical technology company that develops, manufactures and sells products for cardiovascular, ischemic and related indications in the United States. The company offers various DNA-based therapeutic products, including Generx, which is a nonsurgical angiogenic therapy for patients with recurrent angina due to coronary disease. It also offers a preclinical product, Corgentin, which is designed as a one-time cardiomyocyte-directed treatment to promote the repair and restoration of damaged cardiomyocytes and enhance cardiac function following a heart attack. In addition, the company also offers a preclinical, DNA-based, endothelial nitric oxide synthase therapeutic product, Genvascor, which is used for the treatment of patients with critical limb ischemia due to advanced peripheral arterial occlusive disease.